AVAL: Teenagers After London Terrorist Attack

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT03493243
Collaborator
(none)
40
2
30
20
20.3

Study Details

Study Description

Brief Summary

  • Context: Since March 2012, several terrorist attacks have been perpetrated in France (Toulouse, Montauban, Paris, Nice ...). In March 2017, 53 french teenagers were victims in a terrorist attack in London (Westminster Bridge).

  • Main goal = to estimate the psycho-traumatic impact and to describe cares and management of high school students, victims of the terrorist attack in London on 2017, March the 22nd.

  • 3 secondary objectives: 1) Clinical (occurrence of Post Traumatic Stress Disorders or other disorders); 2) Epidemiological (risk factors for developing disorders, avoiding care); 3) Preventive and therapeutic.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaires

Detailed Description

Inclusion criterion: 53 teenagers of Saint-Joseph high school (Concarneau, France) directly exposed to the terrorist attack.

Methodology: self questionnaires and heterogenous questionnaires; descriptive statistics (means +/- standard deviations; search for a significant difference according to traumatic symptomatology)

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
40 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
AVAL Cohort Study First Step, Observational Study, After One Year
Actual Study Start Date :
Mar 14, 2018
Actual Primary Completion Date :
Apr 13, 2018
Actual Study Completion Date :
Apr 13, 2018

Arms and Interventions

Arm Intervention/Treatment
Adolescents exposed

Only clinical questionnaires

Other: Questionnaires
2-hour clinical observation

Outcome Measures

Primary Outcome Measures

  1. PTSD [One year after the terrorist attack (Day 1)]

    Post Traumatic Stress Disorder (Self-Questionnaire :Posttraumatic stress disorder checklist 5 )

Secondary Outcome Measures

  1. Clinical (occurence of Post Traumatic Stress Disorders or other disorders) [One year after the terrorist attack (Day 1)]

    Mini International Neuro-psychiatric Interview for children and adolescent

  2. Epidemiological (risk factors for developing disorders, avoiding care); [One year after the terrorist attack (Day 1)]

    LEC = Life Event checklist

  3. Preventive and therapeutic [One year after the terrorist attack (Day 1)]

    MINI = Mini International Neuropsychiatric Interview

  4. Epidemiological (risk factors for developing disorders, avoiding care); [One year after the terrorist attack (Day 1)]

    ALCES = Adolescent Life Change Event Scale

  5. Epidemiological (risk factors for developing disorders, avoiding care); [One year after the terrorist attack (Day 1)]

    EPS 10 = "Echelle de Provisions Sociales Abrégées";

  6. Epidemiological (risk factors for developing disorders, avoiding care); [One year after the terrorist attack (Day 1)]

    Whodas 2.0 = World Health Organization Disability Assessment Schedule

  7. Preventive and therapeutic [One year after the terrorist attack (Day 1)]

    Questionnaire about use of psychoactive substances

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 20 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 53 teenagers, from Concarneau (France) high school, directly exposed from London terrorist attack (22.03.2017).
Exclusion Criteria:
  • All persons not directly exposed;

  • Relatives of teenagers;

  • 3 physically injured teenagers.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Brest France 29200
2 HIA Hôpital d'Instruction des Armées Clermont Tonnerre Brest France 29200

Sponsors and Collaborators

  • University Hospital, Brest

Investigators

  • Study Director: Nathalie V COULON, MD PhD, CHU Brest

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
COULON Nathalie, medical doctor (psychiatrist for children and teenagers), principal Investigator, University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT03493243
Other Study ID Numbers:
  • AVAL (29BRC17.0248)
First Posted:
Apr 10, 2018
Last Update Posted:
Oct 25, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by COULON Nathalie, medical doctor (psychiatrist for children and teenagers), principal Investigator, University Hospital, Brest
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 25, 2019